These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30070813)

  • 1. Points & Pearls: Cannabinoids: emerging evidence in use and abuse.
    Williams MV; Gupta N; Nusbaum J
    Emerg Med Pract; 2018 Aug; 20(Suppl 8):1-2. PubMed ID: 30070813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoids: emerging evidence in use and abuse.
    Williams MV
    Emerg Med Pract; 2018 Aug; 20(8):1-20. PubMed ID: 30020736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment.
    Richards JR; Lapoint JM; Burillo-Putze G
    Clin Toxicol (Phila); 2018 Jan; 56(1):15-24. PubMed ID: 28730896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
    Besli GE; Ikiz MA; Yildirim S; Saltik S
    J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic drug intoxication in children: recognition and management in the emergency department.
    Shah R; Baum CR
    Pediatr Emerg Med Pract; 2018 May; 15(5):1-20. PubMed ID: 29697923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergency Department Treatment of Cannabinoid Hyperemesis Syndrome: A Review.
    Khattar N; Routsolias JC
    Am J Ther; 2018; 25(3):e357-e361. PubMed ID: 28953512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid hyperemesis syndrome.
    Heise L
    Adv Emerg Nurs J; 2015; 37(2):95-101. PubMed ID: 25929220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid hyperemesis syndrome: a case series and review of previous reports.
    Nicolson SE; Denysenko L; Mulcare JL; Vito JP; Chabon B
    Psychosomatics; 2012; 53(3):212-9. PubMed ID: 22480624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis of cannabinoid hyperemesis : update on the cannabis-shower syndrome].
    Cuppens B; Gensburger M; Tonglet M; Marissiaux L; Brasseur E; d'Orio V; Ghuysen A
    Rev Med Liege; 2016 Dec; 71(12):541-545. PubMed ID: 28387093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosing and treating cannabinoid hyperemesis.
    Wilson O; Lutton S; Doherty K
    Emerg Nurse; 2015 Dec; 23(8):22-5. PubMed ID: 26638755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging drugs of abuse.
    Nelson ME; Bryant SM; Aks SE
    Emerg Med Clin North Am; 2014 Feb; 32(1):1-28. PubMed ID: 24275167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid hyperemesis: a case series.
    Donnino MW; Cocchi MN; Miller J; Fisher J
    J Emerg Med; 2011 Apr; 40(4):e63-6. PubMed ID: 19765941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haloperidol for treatment of cannabinoid hyperemesis syndrome.
    Hickey JL; Witsil JC; Mycyk MB
    Am J Emerg Med; 2013 Jun; 31(6):1003.e5-6. PubMed ID: 23583118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designer drugs. Patients may be using synthetic cannabinoids more than you think.
    Lisi DM
    JEMS; 2014 Sep; 39(9):56-9. PubMed ID: 25322519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed seizure-like activity following analytically confirmed use of previously unreported synthetic cannabinoid analogues.
    Schep LJ; Slaughter RJ; Hudson S; Place R; Watts M
    Hum Exp Toxicol; 2015 May; 34(5):557-60. PubMed ID: 25233895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cannabinoid-induced hyperemesis].
    Lieb M; Palm U; Nicolaus M; Reibke R; Baghai TC
    Psychiatr Prax; 2011 Apr; 38(3):147-9. PubMed ID: 21462097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome in Adolescents: A Case Series.
    Graham J; Barberio M; Wang GS
    Pediatrics; 2017 Dec; 140(6):. PubMed ID: 29122973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review.
    Alves VL; Gonçalves JL; Aguiar J; Teixeira HM; Câmara JS
    Crit Rev Toxicol; 2020 May; 50(5):359-382. PubMed ID: 32530350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and financial implications of emergency department visits for synthetic marijuana.
    Rowley E; Benson D; Tiffee A; Hockensmith A; Zeng H; Jones GN; Musso MW
    Am J Emerg Med; 2017 Oct; 35(10):1506-1509. PubMed ID: 28457767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicology and management of novel psychoactive drugs.
    Kersten BP; McLaughlin ME
    J Pharm Pract; 2015 Feb; 28(1):50-65. PubMed ID: 25261428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.